CN204336925U - Wearable Woundless blood sugar measurement device - Google Patents
Wearable Woundless blood sugar measurement device Download PDFInfo
- Publication number
- CN204336925U CN204336925U CN201420786130.8U CN201420786130U CN204336925U CN 204336925 U CN204336925 U CN 204336925U CN 201420786130 U CN201420786130 U CN 201420786130U CN 204336925 U CN204336925 U CN 204336925U
- Authority
- CN
- China
- Prior art keywords
- infrared light
- module
- wearable
- blood sugar
- measurement device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The utility model discloses a kind of wearable Woundless blood sugar measurement device, comprising: infrared light emission module, for launching the infrared light of preset wavelength to measuring point; Concentration module, for assembling the infrared light of the preset wavelength that infrared light emission module sends; Infrared light receiver module, for receiving the infrared spectroscopy signals of infrared light after decay of preset wavelength, and converts the infrared spectroscopy signals of reception to analog electrical signal; Signal conversion and processing module, carry out analytical calculation, obtain the measurement result of human blood glucose concentration after analog electrical signal being converted to digital signal; First driver module, for regulating the position of infrared light emission module and infrared light receiver module, to determine the maximum position of the infrared Absorption rate of preset wavelength as measuring point; Pressure adjusting module, for detect and the pressure regulating measuring point to be subject to preset pressure limit.This programme solves certainty of measurement difference, resolution is low, and the problem that measurement reproducibility is low.
Description
Technical field
This utility model relates to blood glucose measurement technical field, particularly relates to a kind of wearable Woundless blood sugar measurement device.
Background technology
Diabetics, in order to avoid the complication of diabetes, needs measure continually and control blood sugar concentration, and at present in China, the method major part that diabetics measures blood sugar concentration adopts the blood-glucose meter having wound.The measurement that blood glucose concentration is carried out in blood sampling frequently on the one hand brings huge financial burden and medical expense to diabetics, on the other hand also to the risk that diabetics brings huge health and mental anguish and catches.At present, utilizes noinvasive infrared light to measure blood glucose and have relevant report, but currently used infrared light measures the technology of human blood glucose concentration, has following imperfection part:
One, Measurement Resolution is not enough: use infrared light to measure blood sugar concentration, from the process of reality, because the blood flow volume of end slightly blood is very little, so the amount of infrared light that blood glucose absorbs is less, causes the resolution capability measured very little.
Two, the repeatability measured is not good: existing scheme can not regulate the stressed of measurement point position and tightness, can not solve the measuring accuracy problem of different body types crowd, causes the repeatability of measurement not good.
Three, the accuracy problem measured: what adopt due to existing scheme is end slightly blood, the infrared Absorption amount of end, measuring point slightly blood is little compared with the accounting of the INFRARED ABSORPTION amount of other tissue of human body, thus there is larger measurement error.
Utility model content
Main purpose of the present utility model is to solve that the certainty of measurement of existing Woundless blood sugar measuring method to blood glucose is poor, resolution is low, and the problem that measurement reproducibility is low.
For achieving the above object, this utility model provides a kind of wearable Woundless blood sugar measurement device, and described wearable Woundless blood sugar measurement device comprises:
Infrared light emission module, for launching the infrared light of preset wavelength to measuring point;
Concentration module, is arranged on the front end, infrared emission position of described infrared light emission module, for assembling the infrared light of the described preset wavelength that described infrared light emission module sends;
Infrared light receiver module, for receiving the infrared spectroscopy signals of infrared light after decay of described preset wavelength, and converts the described infrared spectroscopy signals received to analog electrical signal;
Signal conversion and processing module, connect described infrared light receiver module, carry out analytical calculation, obtain the measurement result of human blood glucose concentration after converting described analog electrical signal to digital signal;
First driver module, be connected with described infrared light emission module and infrared light receiver module, for regulating the position of described infrared light emission module and infrared light receiver module, to determine the maximum position of the infrared Absorption rate of preset wavelength as measuring point;
Pressure adjusting module, is connected with described infrared light emission module and infrared light receiver module, for detect and the pressure regulating described measuring point to be subject to preset pressure limit.
Preferably, described pressure adjusting module comprises:
Pressure transducer, is arranged on described infrared light emission module and/or infrared light receiver module near the side of measuring point, for detecting the pressure that described measuring point is subject to;
Second driver module, be connected with described infrared light emission module and infrared light receiver module, the pressure for being subject to measuring point is adjusted to preset pressure limit.
Preferably, described wearable Woundless blood sugar measurement device also comprises:
Data communication module, changes with described signal and processing module is connected, for the measurement result of described human blood glucose concentration is carried out remote transmission.
Preferably, described wearable Woundless blood sugar measurement device also comprises:
Human-computer interaction module, connects the conversion of described signal and processing module, for receiving the instruction of user's input, and shows the measurement result of described human blood glucose concentration or the measurement result by this human blood glucose concentration of voice broadcast.
Preferably, described measuring point is neck arteries.
Preferably, described wearable Woundless blood sugar measurement device also comprises:
Microprocessor, is connected with described first driver module and the second driver module; Regulate the position of described infrared light emission module and infrared light receiver module for controlling the first driver module, and the pressure that control second driver module regulates measuring point to be subject to is to preset pressure limit.
Preferably, described concentration module is condenser lens, meniscus or LED lamp cup.
Preferably, the wave-length coverage of infrared light that the infrared light launched of described infrared light emission module and described infrared light receiver module receive is 800nm to 3800nm.
This utility model launches the infrared light of preset wavelength to measuring point by infrared light emission module, the infrared light of concentration module to this preset wavelength is gathered, receive the infrared spectroscopy signals after decay by infrared light receiver module and convert thereof into analog electrical signal, analytical calculation is carried out after analog electrical signal is converted to digital signal by signal conversion and processing module, obtain the measurement result of human blood glucose concentration, thus improve precision and the resolution of blood glucose measurement; In addition, the position of infrared light emission module and infrared light receiver module is regulated by the first driver module, to determine the maximum position of the infrared Absorption rate of preset wavelength as measuring point, and regulate the pressure that is subject to of measuring point in suitable pressure limit by pressure adjusting module, improve the repeatability of measurement.
Accompanying drawing explanation
Fig. 1 is the structural representation of this utility model wearable Woundless blood sugar measurement device first embodiment;
Fig. 2 is the structural representation of pressure adjusting module in Fig. 1;
Fig. 3 is the structural representation of this utility model wearable Woundless blood sugar measurement device second embodiment;
Fig. 4 is the structural representation of this utility model wearable Woundless blood sugar measurement device the 3rd embodiment.
The realization of this utility model object, functional characteristics and advantage will in conjunction with the embodiments, are described further with reference to accompanying drawing.
Detailed description of the invention
Should be appreciated that specific embodiment described herein only in order to explain this utility model, and be not used in restriction this utility model.
This utility model provides a kind of wearable Woundless blood sugar measurement device.
With reference to the structural representation that Fig. 1, Fig. 1 are this utility model wearable Woundless blood sugar measurement device first embodiment.
In a first embodiment, wearable Woundless blood sugar measurement device comprises:
Infrared light emission module 10, for launching the infrared light of preset wavelength to measuring point; Infrared light is launched to measuring point in real time when measuring;
Concentration module 20, is arranged on the front end, infrared emission position of infrared light emission module, for assembling the infrared light of the preset wavelength that infrared light emission module sends; The infrared light of scattering infrared light emission module 10 sent is gathered;
Infrared light receiver module 30, for receiving the infrared spectroscopy signals of infrared light after decay of preset wavelength, and converts the infrared spectroscopy signals of reception to analog electrical signal;
Signal conversion and processing module 40, connect infrared light receiver module, carry out analytical calculation, obtain the measurement result of human blood glucose concentration after analog electrical signal being converted to digital signal;
First driver module 50, is connected with infrared light emission module and infrared light receiver module, for regulating the position of infrared light emission module and infrared light receiver module, to determine the maximum position of the infrared Absorption rate of preset wavelength as measuring point;
Pressure adjusting module 60, is connected with infrared light emission module and infrared light receiver module, for detect and the pressure regulating measuring point to be subject to preset pressure limit.
System will carry out system initialization after starting startup, comprise and read the initial infrared Absorption rate of initial blood glucose concentration value and blood sugar for human body constant value from memorizer, comprise and initialize some parameters and data (at the beginning of data acquisition, need the blood sugar measuring method carrying out using Wicresoft, obtain this particular measurement personnel blood glucose value, this blood glucose value can manually be input in this system, carries out the measurement of infrared spectrometry to blood glucose simultaneously, obtains code value in infrared light blood glucose).After initialization completes, namely system carries out detecting accessing with or without detection signal, both the measurement whether having tester to carry out blood glucose had been checked, input if any detection signal, just some process carried out to this signal and analyze, as carried out the process of the digital filtering such as debounce, deburring to signal data, some dynamic data analysis and judgements are carried out with to data, judge trend and the trend of data, until this measurement data reads these stable data after tending towards stability, again these data are carried out calculated with mathematical model, thus calculate the concentration measurement of the blood-glucose of person to be measured; Finally the measurement result obtained is exported.
Measuring point selected in the present embodiment can be the neck arteries position of gauger because neck arteries to be positioned at body surface site more shallow, blood flow is comparatively large, and the signal to noise ratio of measuring-signal is high, and certainty of measurement is high; Infrared light emission module 10 can launch the infrared light of at least three different wavelength, namely comprises the infrared light emission pipe of at least three different wave lengths.When measuring, the infrared light of infrared light emission module 10 real time emission wave-length coverage between 800nm to 3800nm; The infrared light sent by the concentration module 20 pairs of infrared light emission modules 10 being arranged on the front end, infrared emission position of infrared light emission module 10 is assembled, the infrared light of scattering is gathered, to overcome the problem such as light scatter and interference of infrared light, make the infrared light maximum of measurement by tissue to be measured, improve resolution and the repeatability of measuring system, this concentration module 20 can adopt condenser lens, meniscus and LED lamp cup etc. to have the device of optically focused effect; When determining measuring point, finely tuned by the position of MCU Microprocessor S3C44B0X first driver module 50 pairs of infrared light emission modules 10 and infrared light receiver module 30, select to the maximum position of the infrared Absorption rate of preset wavelength as measuring point, this to the position that the infrared Absorption rate of preset wavelength is maximum be generally infrared light through the maximum position of vessel area; By the infrared light emission module 10 of pressure adjusting module 60 in real time suffered by detection measuring point and the pressure of infrared light receiver module 30, and the pressure regulating measuring point to be subject to is to preset pressure limit, ensure suitable elasticity, meet the measuring accuracy of different body types crowd.
Time native system carries out blood sugar content measurement, first the characteristic spectrum (such as 1650nm) of a glucose is needed, with the absorbtivity of preliminary surveying glucose to its characteristic light, in order to make glucose more accurate to the absorbtivity of its characteristic light, also need to get rid of water mitigation in this measuring process.In measuring process, the measurement of water to glucose has interference, namely the infrared light of water to the characteristic wavelength of glucose also has absorption, so just need to measure water to the absorbtivity of the infrared light of the characteristic wavelength of glucose at this, then remove in the amount of raw glucose to the part glucose characteristic light that water absorbs by the basis of the absorbtivity of its characteristic light, to obtain the absolute total amount that glucose absorbs its characteristic light.Concrete, the infrared Absorption of glucose to 1400nm is less, and the infrared light of water to this wavelength has stronger absorption, so the absorbtivity (such as 1650nm) of water to the characteristic light of glucose can be substituted by measuring the absorbtivity of water to the infrared light of 1400nm, reject with this interference that water measures glucose content.
Because infrared light has decay to a certain degree after irradiating human body, spectral signal after infrared light receiver module 30 receiving attenuation, and convert this spectral signal to analog electrical signal, it is (concrete that the size of this analog electrical signal and human blood glucose concentration present certain mathematical model relation, in measuring process, the measurement of water to glucose has interference, namely the infrared light of water to the characteristic wavelength of glucose also has absorption, so just need to measure water to the absorbtivity of the infrared light of the characteristic wavelength of glucose at this, then remove in the amount of raw glucose to the part glucose characteristic light that water absorbs by the basis of the absorbtivity of its characteristic light, to obtain the absolute total amount that glucose absorbs its characteristic light).After the infrared signal of decaying converts analog electrical signal to, microprocessor module acceptable digital signal is converted thereof into after the analog electrical signal of reflection blood sugar for human body concentration of glucose is carried out filtering, amplification by signal conversion and processing module 40, then carry out analytical calculation, obtain the measurement result of human blood glucose concentration.
The present embodiment launches the infrared light of preset wavelength to measuring point by infrared light emission module 10, the infrared light of concentration module 20 to this preset wavelength is gathered, receive the infrared spectroscopy signals after decay by infrared light receiver module 30 and convert thereof into analog electrical signal, analytical calculation is carried out after analog electrical signal is converted to digital signal by signal conversion and processing module 40, obtain the measurement result of human blood glucose concentration, thus improve precision and the resolution of blood glucose measurement; In addition, the position of infrared light emission module and infrared light receiver module is regulated by the first driver module 50, to determine the maximum position of the infrared Absorption rate of preset wavelength as measuring point, and the pressure regulating measuring point to be subject to by pressure adjusting module 60 is in suitable pressure limit, improves the repeatability of measurement.
Further, the drive singal of infrared light emission module 10 is pulse signals, and the scope of the dutycycle of this pulse signal is 1:20 to 1:1.5.In order to solve the fluctuation problem of infrared emission light light intensity and increase the penetration capacity of infrared light, the dutycycle of impulse wave is from 1:1.5 to 1:20, so just preferably resolves the problem that infrared light drives fluctuation.When dutycycle is less than 1:20 time, light intensity and the luminous flux of institute's emission characteristic light are too little, penetrate poor effect, do not reach measurement requirement; When dutycycle is greater than 1:1.5, there is larger fluctuation in the light intensity of institute's emission characteristic light and luminous flux, and the error of measurement result is comparatively large, does not also reach and measures needs.
Further, wearable Woundless blood sugar measurement device also comprises the driving power for driving infrared light emission module 10 and infrared light receiver module 30, and the ripple of driving power is less than 100mv.Due under identical power drives, the infrared light that infrared light emission pipe is launched is not identical, and it always has fluctuation, and this can cause larger error to measurement.In the present embodiment in order to reduce this error, infrared light emission module 10 is identical with the driving power of infrared light receiver module 30, when the ripple of this supply voltage is less, the light flux variations rate of infrared light can be made to reduce, the fluctuation of the infrared light that infrared light emission pipe is launched is also less, concrete, the ripple of this power supply is less than 100mv.
Further, the input end signal voltage difference of signal conversion and processing module 40 is less than 50mv, and signal is changed and the signal switching rate of processing module 40 is 10HZ to 1000HZ.The output signal of sensor belongs to small-signal, and generally at below 10mv, signal input part voltage difference is less than 50mv, because the amplification of amplifier to 100 times, can exceed this voltage and can cause the scope of the output voltage of amplifier and the inefficacy of amplifier.The reason of selection 10HZ to 1000HZ is: if be less than 10HZ, then the speed of data sampling and analysis is too slow, can not realize the object measured in real time preferably; If be greater than 1000HZ simultaneously, sampling rate is too fast, and many data can be caused not carry out analysis will be abandoned, simultaneously too high sampling rate, also can cause the data instability of sampling.
Further, infrared light emission module 10 comprises infrared light emission circuit and power circuit; Infrared light receiver module 30 comprises infrared light receiving circuit and power circuit; Signal conversion and processing module 40 comprise filter circuit, signal amplification circuit, signal selecting circuit, signaling conversion circuit, microcontroller circuit and power circuit.
With reference to the structural representation that Fig. 2, Fig. 2 are pressure adjusting module in Fig. 1.
In the above-described embodiments, pressure adjusting module 60 comprises:
Pressure transducer 61, is arranged on infrared light emission module and/or infrared light receiver module near the side of measuring point, for detecting the pressure that measuring point is subject to;
Second driver module 62, is connected with infrared light emission module and infrared light receiver module, and the pressure for being subject to measuring point is adjusted to preset pressure limit.
In infrared light emission module 10 and/or infrared light receiver module 30, pressure transducer 61 is set near the side of measuring point, infrared light emission module 10 suffered by the measuring point of real-time human body and the pressure of infrared light receiver module 30, and the force value detected is sent to MCU microprocessor, MCU microprocessor controls the second driver module 62 according to preset pressure limit and works, with the elasticity regulating infrared light emission module 10 to contact the measuring point of human body with infrared light receiver module 30, be adjusted in preset pressure limit with the pressure that measuring point is subject to.
The pressure of measuring point is detected by pressure transducer 61, and according to the stressed and tightness of the size adjustment measurement point position of pressure in preset pressure limit, thus solve the measuring accuracy problem of different body types crowd, improve measurement reproducibility.
With reference to the structural representation that Fig. 3, Fig. 3 are this utility model wearable Woundless blood sugar measurement device second embodiment.
On the basis of above-mentioned wearable Woundless blood sugar measurement device first embodiment, in the second embodiment, wearable Woundless blood sugar measurement device also comprises:
Data communication module 70, is connected with data processing module, for the measurement result of human blood glucose concentration is carried out remote transmission; This data communication module 70 comprises microcontroller circuit and data communication circuit.
Data communication module 70 changes with signal and processing module 40 is connected, after signal conversion and processing module 40 record the measurement result of human blood glucose concentration, measurement result transferred to by data communication module 70 platform that health control platform etc. is used for providing health service, also can transfer in the terminal units such as the mobile phone of user, carry out self management or supervision and management for user, thus realize the Informatization Service functions such as the remote data transmission of wearable Woundless blood sugar measurement device.
With reference to the structural representation that Fig. 4, Fig. 4 are this utility model wearable Woundless blood sugar measurement device the 3rd embodiment.
On the basis of above-mentioned wearable Woundless blood sugar measurement device first embodiment, in the 3rd embodiment, wearable Woundless blood sugar measurement device also comprises:
Human-computer interaction module 80, connection signal conversion and processing module 40, for receiving the instruction of user's input, and show the measurement result of human blood glucose concentration or the measurement result by this human blood glucose concentration of voice broadcast; Human-computer interaction module 80 comprises microcontroller circuit, input circuit and display circuit.
Human-computer interaction module 80 can provide the control button or control inerface that open and close for user's control system, inputs open command or out code for user; Further, after signal conversion and processing module 40 calculate the measurement result of human blood glucose concentration, the measurement result of human blood glucose concentration shows by human-computer interaction module 80, or reports out the measurement result of human blood glucose concentration by the mode of voice broadcast.
These are only preferred embodiment of the present utility model; not thereby the scope of the claims of the present utility model is limited; every utilize this utility model description and accompanying drawing content to do equivalent structure or equivalent flow process conversion; or be directly or indirectly used in other relevant technical fields, be all in like manner included in scope of patent protection of the present utility model.
Claims (8)
1. a wearable Woundless blood sugar measurement device, is characterized in that, described wearable Woundless blood sugar measurement device comprises:
Infrared light emission module, for launching the infrared light of preset wavelength to measuring point;
Concentration module, is arranged on the front end, infrared emission position of described infrared light emission module, for assembling the infrared light of the described preset wavelength that described infrared light emission module sends;
Infrared light receiver module, for receiving the infrared spectroscopy signals of infrared light after decay of described preset wavelength, and converts the described infrared spectroscopy signals received to analog electrical signal;
Signal conversion and processing module, connect described infrared light receiver module, carry out analytical calculation, obtain the measurement result of human blood glucose concentration after converting described analog electrical signal to digital signal;
First driver module, be connected with described infrared light emission module and infrared light receiver module, for regulating the position of described infrared light emission module and infrared light receiver module, to determine the maximum position of the infrared Absorption rate of preset wavelength as measuring point;
Pressure adjusting module, is connected with described infrared light emission module and infrared light receiver module, for detect and the pressure regulating described measuring point to be subject to preset pressure limit.
2. wearable Woundless blood sugar measurement device as claimed in claim 1, it is characterized in that, described pressure adjusting module comprises:
Pressure transducer, is arranged on described infrared light emission module and/or infrared light receiver module near the side of measuring point, for detecting the pressure that described measuring point is subject to;
Second driver module, be connected with described infrared light emission module and infrared light receiver module, the pressure for being subject to measuring point is adjusted to preset pressure limit.
3. wearable Woundless blood sugar measurement device as claimed in claim 1 or 2, is characterized in that, described wearable Woundless blood sugar measurement device also comprises:
Data communication module, changes with described signal and processing module is connected, for the measurement result of described human blood glucose concentration is carried out remote transmission.
4. wearable Woundless blood sugar measurement device as claimed in claim 1, is characterized in that, described wearable Woundless blood sugar measurement device also comprises:
Human-computer interaction module, connects the conversion of described signal and processing module, for receiving the instruction of user's input, and shows the measurement result of described human blood glucose concentration or the measurement result by this human blood glucose concentration of voice broadcast.
5. wearable Woundless blood sugar measurement device as claimed in claim 1, is characterized in that, described measuring point is neck arteries.
6. wearable Woundless blood sugar measurement device as claimed in claim 2, is characterized in that, described wearable Woundless blood sugar measurement device also comprises:
Microprocessor, is connected with described first driver module and the second driver module; Regulate the position of described infrared light emission module and infrared light receiver module for controlling the first driver module, and the pressure that control second driver module regulates measuring point to be subject to is to preset pressure limit.
7. wearable Woundless blood sugar measurement device as claimed in claim 1, is characterized in that, described concentration module is condenser lens, meniscus or LED lamp cup.
8. wearable Woundless blood sugar measurement device as claimed in claim 1, is characterized in that, the wave-length coverage of the infrared light that described infrared light emission module is launched and the infrared light that described infrared light receiver module receives is 800nm to 3800nm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420786130.8U CN204336925U (en) | 2014-12-06 | 2014-12-06 | Wearable Woundless blood sugar measurement device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420786130.8U CN204336925U (en) | 2014-12-06 | 2014-12-06 | Wearable Woundless blood sugar measurement device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204336925U true CN204336925U (en) | 2015-05-20 |
Family
ID=53220236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420786130.8U Expired - Fee Related CN204336925U (en) | 2014-12-06 | 2014-12-06 | Wearable Woundless blood sugar measurement device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204336925U (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105433953A (en) * | 2015-11-28 | 2016-03-30 | 深圳市前海安测信息技术有限公司 | Blood sugar data acquisition system and method based on photoelectric signals |
| WO2016086448A1 (en) * | 2014-12-06 | 2016-06-09 | 深圳市前海安测信息技术有限公司 | Spectroscopy technique based non-invasive blood glucose measurement system and measurement method thereof |
| CN105919601A (en) * | 2016-04-13 | 2016-09-07 | 武汉美迪威斯无线传感医学设备有限公司 | Non-invasive blood glucose detector and method |
| WO2017140116A1 (en) * | 2016-02-20 | 2017-08-24 | 深圳市前海安测信息技术有限公司 | Non-invasive auxiliary device for detecting blood glucose concentration |
| CN108261202A (en) * | 2016-12-30 | 2018-07-10 | 北京大学 | A kind of system and its application method for measuring blood glucose |
| CN108601529A (en) * | 2015-12-31 | 2018-09-28 | 威尔图比有限公司 | The equipment, system and method for non-invasive monitoring for physiological measurements |
| WO2018192257A1 (en) * | 2017-04-21 | 2018-10-25 | 深圳市前海安测信息技术有限公司 | Wristwatch having function for noninvasively collecting blood sugar data |
| CN111317443A (en) * | 2018-12-14 | 2020-06-23 | 天津先阳科技发展有限公司 | Noninvasive detection device, system and wearable equipment are divided into to equipment |
| CN113017621A (en) * | 2021-04-22 | 2021-06-25 | 恒玄科技(上海)股份有限公司 | Wearable equipment |
| CN116035571A (en) * | 2022-10-31 | 2023-05-02 | 深圳市彩鸿虚拟现实科技有限公司 | Intelligent noninvasive glucometer |
| RU2795554C2 (en) * | 2018-12-14 | 2023-05-05 | Тяньцзинь Санрайз Текнолоджис Дивелопмент Ко., Лтд. | Method, device, system and wearable device for non-invasive detection for tissue element |
-
2014
- 2014-12-06 CN CN201420786130.8U patent/CN204336925U/en not_active Expired - Fee Related
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016086448A1 (en) * | 2014-12-06 | 2016-06-09 | 深圳市前海安测信息技术有限公司 | Spectroscopy technique based non-invasive blood glucose measurement system and measurement method thereof |
| CN105433953A (en) * | 2015-11-28 | 2016-03-30 | 深圳市前海安测信息技术有限公司 | Blood sugar data acquisition system and method based on photoelectric signals |
| CN108601529A (en) * | 2015-12-31 | 2018-09-28 | 威尔图比有限公司 | The equipment, system and method for non-invasive monitoring for physiological measurements |
| CN108601529B (en) * | 2015-12-31 | 2022-02-25 | 威尔图比有限公司 | Apparatus, system and method for non-invasive monitoring of physiological measurements |
| WO2017140116A1 (en) * | 2016-02-20 | 2017-08-24 | 深圳市前海安测信息技术有限公司 | Non-invasive auxiliary device for detecting blood glucose concentration |
| CN105919601A (en) * | 2016-04-13 | 2016-09-07 | 武汉美迪威斯无线传感医学设备有限公司 | Non-invasive blood glucose detector and method |
| CN108261202A (en) * | 2016-12-30 | 2018-07-10 | 北京大学 | A kind of system and its application method for measuring blood glucose |
| WO2018192257A1 (en) * | 2017-04-21 | 2018-10-25 | 深圳市前海安测信息技术有限公司 | Wristwatch having function for noninvasively collecting blood sugar data |
| CN111317443A (en) * | 2018-12-14 | 2020-06-23 | 天津先阳科技发展有限公司 | Noninvasive detection device, system and wearable equipment are divided into to equipment |
| CN111317443B (en) * | 2018-12-14 | 2023-01-24 | 天津先阳科技发展有限公司 | Noninvasive detection device, system and wearable equipment are divided into to equipment |
| RU2795554C2 (en) * | 2018-12-14 | 2023-05-05 | Тяньцзинь Санрайз Текнолоджис Дивелопмент Ко., Лтд. | Method, device, system and wearable device for non-invasive detection for tissue element |
| CN113017621A (en) * | 2021-04-22 | 2021-06-25 | 恒玄科技(上海)股份有限公司 | Wearable equipment |
| CN116035571A (en) * | 2022-10-31 | 2023-05-02 | 深圳市彩鸿虚拟现实科技有限公司 | Intelligent noninvasive glucometer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN204336925U (en) | Wearable Woundless blood sugar measurement device | |
| CN104490403A (en) | Non-invasive blood glucose measurement system and measurement method based on spectrum technology | |
| CN103876726B (en) | A kind of intelligent cardiac monitor device based on potential and photoelectric detecting method | |
| CN104257390B (en) | Woundless blood sugar assay method and system | |
| CN101936896B (en) | Alcohol gas concentration laser telemetering device | |
| CN102755167A (en) | Apparatus and method for non-invasive blood glucose monitoring and method for analysing biological molecule | |
| CN201564481U (en) | Non-invasive blood glucose monitoring analyzer | |
| CN106955090B (en) | Pulse feeling device, gas detection device, pulse simulating device and traditional Chinese medicine diagnosis and treatment system | |
| CN114403904A (en) | Device for determining muscle state based on electromyographic signals and muscle blood oxygen saturation | |
| CN104873207A (en) | Terahertz wave-based continuous blood glucose measurement system | |
| CN203763090U (en) | Light transmittance waveform oximeter | |
| CN104856697A (en) | Finger recognition method of reflectance oximetry | |
| CN105334166A (en) | Dual-detector near-infrared spectroscopy used for food composition analysis | |
| CN203016941U (en) | Photoelectric type heart rate measuring circuit | |
| CN109406452A (en) | A kind of formaldehyde examination device and detection method based on middle Laser Regulated in Ultrared Band | |
| CN102973259A (en) | Photoelectric heart rate measuring circuit | |
| CN205658894U (en) | Infrared sphygmometer based on singlechip | |
| CN205031270U (en) | Infrared light noninvasive blood glucose sensing appearance with teletransmission function | |
| CN204989031U (en) | Light signal transmission detects head | |
| CN104013385A (en) | Skin sebum transferring probe and skin sebum secretion measuring method and device | |
| CN103989483A (en) | Non-intrusive laser blood glucose painless detection carrying system | |
| CN203898313U (en) | Oxyhemoglobin saturation measuring instrument and blood oxygen probe thereof | |
| CN210784361U (en) | Noninvasive blood glucose detection system | |
| CN105232055A (en) | Noninvasive glucometer | |
| CN104236862B (en) | Optical performance test method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150923 Address after: 518063 Guangdong city of Shenzhen province Qianhai Shenzhen Hong Kong cooperation zone before Bay Road No. 1 building 201 room A (located in Shenzhen Qianhai business secretary Co. Ltd.) Patentee after: BIO-TECH ACADEMY (CHINA) Co.,Ltd. Address before: 518048 Guangdong city of Shenzhen province Futian District Futian Free Trade Zone, Yingdali technology digital park A building 706-709 room Patentee before: E-TECHNO INFORMATION TECHNOLOGIES Co.,Ltd. Patentee before: ANYCHECK INFORMATION TECHNOLOGIES Co.,Ltd. Patentee before: BIO-TECH ACADEMY (CHINA) Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150520 Termination date: 20211206 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |